The CXCR4-tropic human immunodeficiency virus envelope promotes more-efficient gene delivery to resting CD4+ T cells than the vesicular stomatitis virus glycoprotein G envelope

Journal of Virology

Volumn 83, Issue 16, 2009, Pages 8153-8162

  Agosto, Luis M ^a   Yu, Jianqing J ^a   Liszewski, Megan K ^b   Baytop, Clifford ^a   Korokhov, Nikolay ^c   Humeau, Laurent M ^c   O'Doherty, Una ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c VIRxSYS Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; LENTIVIRUS VECTOR; VIRUS GLYCOPROTEIN;

ARTICLE; BACTERIAL GENE; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL FUNCTION; CONTROLLED STUDY; GENE ACTIVATION; GENE TARGETING; GENE TRANSFER; HUMAN IMMUNODEFICIENCY VIRUS; INOCULATION; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION; SIGNAL TRANSDUCTION; VESICULAR STOMATITIS VIRUS; VIROTHERAPY; VIRUS ATTACHMENT; VIRUS DNA CELL DNA INTERACTION; VIRUS ENVELOPE; VIRUS GENE; VIRUS INFECTIVITY; VIRUS PARTICLE;

CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; ENV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HIV; HIV INFECTIONS; HUMANS; MEMBRANE FUSION; MEMBRANE GLYCOPROTEINS; PROTEIN BINDING; RECEPTORS, CXCR4; VIRAL ENVELOPE PROTEINS; VIRUS INTEGRATION;

HUMAN IMMUNODEFICIENCY VIRUS; VESICULAR STOMATITIS VIRUS;

EID: 67749131112     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00220-09     Document Type: Article

References (65)

1. Adachi, A., H. E. Gendelman, S. Koenig, T. Folks, R. Willey, A. Rabson, and M. A. Martin. 1986. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59:284-291.
2. + T cells even at low inoculums as demonstrated with an improved assay for HIV-1 integration. Virology 368:60-72.
3. Aiuti, A. 2002. Advances in gene therapy for ADA-deficient SCID. Curr. Opin. Mol. Ther. 4:515-522.
4. + cells with a human immunodeficiency virus type 1-based retroviral vector pseudotyped with vesicular stomatitis virus envelope glycoprotein G. J. Virol. 70:2581-2585.
5. Bukrinsky, M. I., T. L. Stanwick, M. P. Dempsey, and M. Stevenson. 1991. Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection. Science 254:423-427.
6. + T cells. Science 276:273-276.
7. Cavrois, M., C. De Noronha, and W. C. Greene. 2002. A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes. Nat. Biotechnol. 20:1151-1154.
8. + T cells. Nature 435:108-114.
9. Coil, D. A., and A. D. Miller. 2004. Phosphatidylserine is not the cell surface receptor for vesicular stomatitis virus. J. Virol. 78:10920-10926.
10. Connor, R. I., B. K. Chen, S. Choe, and N. R. Landau. 1995. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology 206:935-944.
11. Cronin, J., X. Y. Zhang, and J. Reiser. 2005. Altering the tropism of lentiviral vectors through pseudotyping. Curr. Gene Ther. 5:387-398.
12. + T cells but enters naive cells less efficiently than memory cells. J. Virol. 83:4528-4537.
13. Ducrey-Rundquist, O., M. Guyader, and D. Trono. 2002. Modalities of interleukin-7-Induced human immunodeficiency virus permissiveness in quiescent T lymphocytes. J. Virol. 76:9103-9111.
14. Foley, G. E., A. H. Handler, P. M. Lynch, S. R. Wolman, C. S. Stolberg, and H. Eagle. 1965. Loss of neoplastic properties in vitro. II. Observations on KB sublines. Cancer Res. 25:1254-1261.
15. Fomina, A. F., T. J. Deerinck, M. H. Ellisman, and M. D. Cahalan. 2003. Regulation of membrane trafficking and subcellular organization of endocytic compartments revealed with FM1-43 in resting and activated human T cells. Exp. Cell Res. 291:150-166.
16. Fouchier, R. A. M., B. E. Meyer, J. H. M. Simon, U. Fischer, and M. H. Malim. 1997. HIV-1 infection of non-dividing cells: evidence that the amino-terminal basic region of the viral matrix protein is important for Gag processing but not for post-entry nuclear import. Eur. Mol. Biol. Org. J. 16:4531-4539.
17. Frecha, C., C. Costa, D. Negre, E. Gauthier, S. J. Russell, F. L. Cosset, and E. Verhoeyen. 2008. Stable transduction of quiescent T-cells without induction of cycle progression by a novel lentiviral vector pseudotyped with measles virus glycoproteins. Blood 112:4843-4852.
18. + cells in non-obese diabetic/severe combined immunedeficient mice. Blood 92:2641-2649.
19. cdc2 activity. J. Virol. 69:6705-6711.
20. Hoffman, T. L., C. C. LaBranche, W. Zhang, G. Canziani, J. Robinson, I. Chaiken, J. A. Hoxie, and R. W. Doms. 1999. Stable exposure of the coreceptor-binding site in a CD4-independent HIV-1 envelope protein. Proc. Natl. Acad. Sci. USA 96:6359-6364.
21. + infected patients grouped according to CD4 count and viral load. Mol. Ther. 9:902-913.
22. Johannsdottir, H. K., R. Mancini, J. Kartenbeck, L. Amato, and A. Helenius. 2009. Host cell factors and functions involved in vesicular stomatitis virus entry. J. Virol. 83:440-453.
23. June, C. H. 2007. Adoptive T cell therapy for cancer in the clinic. J. Clin. Investig. 117:1466-1476.
24. Korin, Y. D., and J. A. Zack. 1999. Nonproductive human immunodeficiency virus type 1 infection in nucleoside-treated G0 lymphocytes. J. Virol. 73:6526-6532.
25. Korin, Y. D., and J. A. Zack. 1998. Progression to the G1b phase of the cell cycle is required for completion of human immunodeficiency virus type 1 reverse transcription in T cells. J. Virol. 72:3161-3168.
26. LaBranche, C. C., T. L. Hoffman, J. Romano, B. S. Haggarty, T. G. Edwards, T. J. Matthews, R. W. Doms, and J. A. Hoxie. 1999. Determinants of CD4 independence for a human immunodeficiency virus type 1 variant map outside regions required for coreceptor specificity. J. Virol. 73:10310-10319.
27. Le Blanc, I., P. P. Luyet, V. Pons, C. Ferguson, N. Emans, A. Petiot, N. Mayran, N. Demaurex, J. Faure, R. Sadoul, R. G. Parton, and J. Gruenberg. 2005. Endosome-to-cytosol transport of viral nucleocapsids. Nat. Cell Biol. 7:653-664.
28. Liu, T. C., and D. Kirn. 2008. Gene therapy progress and prospects cancer: oncolytic viruses. Gene Ther. 15:877-884.
29. Lori, R., F. di Marzo Veronese, A. L. De Vico, P. Lusso, J. Reitz, M. S., and R. C. Gallo. 1992. Viral DNA carried by human immunodeficiency virus type 1 virions. J. Virol. 66:5067-5074.
30. Louache, F., N. Debili, A. Marandin, L. Coulombel, and W. Vainchenker. 1994. Expression of CD4 by human hematopoietic progenitors. Blood 84:3344-3355.
31. Lu, X., L. Humeau, V. Slepushkin, G. Binder, Q. Yu, T. Slepushkina, Z. Chen, R. Merling, B. Davis, Y. N. Chang, and B. Dropulic. 2004. Safe two-plasmid production for the first clinical lentivirus vector that achieves >99% transduction in primary cells using a one-step protocol. J. Gene Med. 6:963-973.
32. Marktel, S., Z. Magnani, F. Ciceri, S. Cazzaniga, S. R. Riddell, C. Traversari, C. Bordignon, and C. Bonini. 2003. Immunologic potential of donor lymphocytes expressing a suicide gene for early immune reconstitution after hematopoietic T-cell-depleted stem cell transplantation. Blood 101:1290-1298.
33. Marsh, M., E. Bolzau, and A. Helenius. 1983. Penetration of Semliki Forest virus from acidic prelysosomal vacuoles. Cell 32:931-940.
34. Michie, C. A., A. McLean, C. Alcock, and P. C. L. Beverley. 1992. Lifespan of human lymphocyte subsets defined by CD45 isoforms. Nature 360:264-265.
35. Miyauchi, K., Y. Kim, O. Latinovic, V. Morozov, and G. B. Melikyan. 2009. HIV enters cells via endocytosis and dynamin-dependent fusion with endosomes. Cell 137:433-444.
36. Naldini, L., U. Blömer, P. Gallay, D. Ory, R. Mulligan, F. H. Gage, I. M. Verma, and D. Trono. 1996. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272:263-267.
37. Nara, P. L., and P. J. Fischinger. 1988. Quantitative infectivity assay for HIV-1 and -2. Nature 332:469-470.
38. O'Doherty, U. 2005. Mechanisms of human immunodeficiency virus-1 latency. Transfusion 45:88S-91S.
39. O'Doherty, U., W. J. Swiggard, D. Jeyakumar, D. McGain, and M. H. Malim. 2002. A sensitive, quantitative, assay for human immunodeficiency virus type 1 integration. J. Virol. 76:10942-10950.
40. O'Doherty, U., W. J. Swiggard, and M. H. Malim. 2000. Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding. J. Virol. 74:10074-10080.
41. + T cells. J. Virol. 81:13938-13942.
42. Reiser, J., G. Harmison, S. Kleupfel-Stahl, R. O. Brady, S. Karlsson, and M. Schubert. 1996. Transduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles. Proc. Natl. Acad. Sci. USA 93:15266-15271.
43. Riley, J. L., R. G. Carroll, B. L. Levine, W. Bernstein, D. C. St Louis, O. S. Weislow, and C. H. June. 1997. Intrinsic resistance to T cell infection with HIV type 1 induced by CD28 costimulation. J. Immunol. 158:5545-5553.
44. Rossi, J. J., C. H. June, and D. B. Kohn. 2007. Genetic therapies against HIV. Nat. Biotechnol. 25:1444-1454.
45. Schlegel, R., T. S. Tralka, M. C. Willingham, and I. Pastan. 1983. Inhibition of VSV binding and infectivity by phosphatidylserine: is phosphatidylserine a VSV-binding site? Cell 32:639-646.
46. Sheehy, A. M., N. C. Gaddis, J. D. Choi, and M. H. Malim. 2002. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418:646-650.
47. -/lo cells in G0. Blood 105:3109-3116.
48. Stevenson, M., T. L. Stanwick, M. P. Dempsey, and C. A. Lamonica. 1990. HIV-1 replication is controlled at the level of T cell activation and proviral integration. Eur. Mol. Biol. Org. J. 9:1551-1560.
49. Sun, X., V. K. Yau, B. J. Briggs, and G. R. Whittaker. 2005. Role of clathrin-mediated endocytosis during vesicular stomatitis virus entry into host cells. Virology 338:53-60.
50. Sun, Y., and E. A. Clark. 1999. Expression of the c-myc proto-oncogene is essential for HIV-1 infection in activated T cells. J. Exp. Med. 9:1391-1397.
51. Sutton, R. E., M. J. Reitsma, N. Uchida, and P. O. Brown. 1999. Transduction of human progenitor hematopoietic stem cells by human immunodeficiency virus type 1-based vectors is cell cycle dependent. J. Virol. 73:3649-3660.
52. + T cells in the absence of activating stimuli. J. Virol. 79:14179-14188.
53. Toba, K., E. F. Winton, T. Koike, and A. Shibata. 1995. Simultaneous three-color analysis of the surface phenotype and DNA-RNA quantitation using 7-amino-actinomycin D and pyronin Y. J. Immunol. Methods 182:193-207.
54. Tobiume, M., J. E. Lineberger, C. A. Lundquist, M. D. Miller, and C. Aiken. 2003. Nef does not affect the efficiency of human immunodeficiency virus type 1 fusion with target cells. J. Virol. 77:10645-10650.
55. Tough, D. F., and J. Sprent. 1994. Turnover of naive- and memory-phenotype T cells. J. Exp. Med. 179:1127-1135.
56. Trono, D. 1992. Partial reverse transcripts in virions from human immunodeficiency and murine leukemia viruses. J. Virol. 66:4893-4900.
57. Unutmaz, D., V. N. KewalRamani, S. Marmon, and D. R. Littman. 1999. Cytokine signals are sufficient for HIV-1 infection of resting human T lymphocytes. J. Exp. Med. 189:1735-1746.
58. + T cells. J. Virol. 81:3574-3582.
59. Verhoeyen, E., V. Dardalhon, O. Ducrey-Rundquist, D. Trono, N. Taylor, and F. L. Cosset. 2003. IL-7 surface-engineered lentiviral vectors promote survival and efficient gene transfer in resting primary T lymphocytes. Blood 101:2167-2174.
60. Vogt, V. M., and M. N. Simon. 1999. Mass determination of Rous sarcoma virus virions by scanning transmission electron microscopy. J. Virol. 73:7050-7055.
61. Weng, N. P., B. L. Levine, C. H. June, and R. J. Hodes. 1995. Human naive and memory T lymphocytes differ in telomeric length and replicative potential. Proc. Natl. Acad. Sci. USA 92:11091-11094.
62. Yamashita, M., and M. Emerman. 2006. Retroviral infection of non-dividing cells: old and new perspectives. Virology 344:88-93.
63. Zack, J. A., S. J. Arrigo, S. R. Weitsman, A. S. Go, A. Haislip, and I. S. Y. Chen. 1990. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61:213-222.
64. Zack, J. A., A. M. Haislip, P. Krogstad, and I. S. Y. Chen. 1992. Incompletely reverse-transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retroviral life cycle. J. Virol. 66:1717-1725.
65. Zhang, H., Y. Zhang, T. P. Spicer, L. Z. Abbott, M. Abbott, and B. J. Poiesz. 1993. Reverse transcription takes place within extracellular HIV-1 virions: potential biological significance. AIDS Res. Hum. Retrovir. 9:1287-1296.